The chart below shows how IPGP performed 10 days before and after its earnings report, based on data from the past quarters. Typically, IPGP sees a +3.48% change in stock price 10 days leading up to the earnings, and a -0.92% change 10 days following the report. On the earnings day itself, the stock moves by -2.80%. This data can give you a slight idea of what to expect for the next quarter's release.
Positive
Q4 2024 Revenue Guidance: Revenue guidance for Q4 2024 is expected to be between $210 million and $240 million, reflecting a positive outlook for the upcoming quarter.
Acquisition Revenue Boost: The acquisition of Clean LASER is expected to add approximately $30 million to revenue in the first year, enhancing the company's growth potential.
Strong Financial Position: The company ended the quarter with $1 billion in cash and no debt, indicating a strong financial position.
Adjusted Gross Margin Performance: Adjusted gross margin was reported at 36%, above the midpoint of guidance, showcasing effective cost management and operational efficiency.
Share Repurchase Success: The company has successfully executed share repurchases totaling $74 million in Q3 2024, contributing to shareholder value.
Negative
Third Quarter Revenue Decline: Revenue in the third quarter was $233 million, a decline of 23% year-over-year and down 8% sequentially when adjusted for Russian revenue, which was $7 million in the quarter.
Materials Processing Revenue Decline: Revenue from materials processing applications decreased 22% year-over-year primarily due to lower cutting sales, while revenue from other applications decreased 28% due to unevenness in medical and advanced applications sales.
Gross Margin Decline: GAAP gross margin was 23.2%, a decrease of over 20 percentage points year-over-year primarily due to excess inventory provisions, which provided a 12.8 percentage point headwind to GAAP gross margin this quarter.
Operating Loss Breakdown: GAAP operating loss was $253 million and included a $198 million loss on sale of assets related to the disposal of our Russian operations and $27 million in asset impairment charges due to recent EU trade controls, which curtailed our ability to operate in Belarus.
Net Loss and Adjusted EPS: We reported a net loss of $234 million or $5.33 per diluted share, excluding loss on sale of assets, asset impairment charges and excess inventory provisions, our adjusted EPS was $0.29 in the third quarter at the top of our guidance.
IPG Photonics Corporation (IPGP) Q3 2024 Earnings Call Transcript
IPGP.O
-1.68%